clinical trials for glp-1 obesity meds actively recruiting Data Mega-Collection of and Obesity-Related Trials: Primary Inclusion Criteria from All Studies and Highlights of Clinical Efficacy Analysis of Drugs GLP-1 Receptor Agonist and Size:30 mg/mL (30 mL) (Peppermint) Organic Seasoning

clinical trials for glp-1 obesity meds actively recruiting Data Mega-Collection of and Obesity-Related Trials: Primary Inclusion Criteria from All Studies and Highlights of Clinical Efficacy Analysis of Drugs GLP-1 Receptor Agonist and Size:30 mg/mL (30 mL) (Peppermint) Organic Seasoning

GLP-1 Receptor Agonist and Incretin medication MUST: ✓ Metabolic Physician Supervised Program – regular visits with Dr Cywes and Sheryl ✓ Be on a ketogenic LCHF diet – omnicarnivore or carnivore –

“Anovulatory, premenopausal women with obesity and PCOS, without any severe chronic illness, provided us a homogeneous clinical population to control key variables known to affect taste perception, including sex, age, smoking, diabetes and other chronic conditions, as well as variability related to cyclical hormonal fluctuations,” says Janež

Organic Seasoning

Size:30 mg/mL (30 mL) (Peppermint)

GIP receptor signaling has been investigated in connection with: glucose-dependent insulin secretion pancreatic beta-cell activity nutrient sensing adipose tissue biology lipid metabolism central metabolic signaling The combination of GIP and GLP-1 receptor activity is particularly important because it forms the basis of dual incretin agonism